{"clarifying_information": [{"clarifying_question1": "Are you specifically interested in the technical challenges and innovations related to scaling up upstream (cell culture/production) and downstream (purification) processes for recombinant antibody manufacturing?", "clarifying_answer1": {"clarifying_answer": "Yes, I am specifically interested in the technical challenges and innovations associated with scaling up both upstream (cell culture/production) and downstream (purification) processes for large-scale recombinant antibody manufacturing."}}, {"clarifying_question2": "Do you want a detailed comparison of the challenges and solutions between different expression platforms used for large-scale recombinant antibody production, such as mammalian versus bacterial versus plant systems?", "clarifying_answer2": {"clarifying_answer": "Yes, I would like a detailed comparison of the challenges and solutions associated with large-scale recombinant antibody production across different expression platforms, including mammalian, bacterial, and plant systems."}}, {"clarifying_question3": "Are you seeking information focused on economic and facility-scale considerations (e.g., cost reduction strategies, adoption of continuous manufacturing, infrastructure modernization) for large-scale antibody production?", "clarifying_answer3": {"clarifying_answer": "Yes, I am interested in information focused on economic and facility-scale considerations such as cost reduction strategies, adoption of continuous manufacturing, and infrastructure modernization for large-scale antibody production."}}], "better_queries_2": {"reformulated1": "What are the specific technical challenges and recent innovations in scaling up both upstream (cell culture/production) and downstream (purification) processes for large-scale recombinant antibody manufacturing?", "reformulated2": "How do the production challenges and technological solutions for large-scale recombinant antibody manufacturing compare across mammalian, bacterial, and plant-based expression platforms?", "reformulated3": "What strategies and technological advances are being used to address economic and facility-scale challenges, including cost reduction, implementation of continuous manufacturing, and modernization of infrastructure, in large-scale recombinant antibody production?"}}
